Navigation Links
HC Innovations Wishes James Bigl Continued Success
Date:9/12/2008

SHELTON, Conn., Sept. 12 /PRNewswire-FirstCall/ -- HC Innovations, Inc. (OTC Bulletin Board: HCNV, http://www.hcinnovationsinc.com ), a specialty care management company providing high-touch services to patients with complex medical needs, while producing cost savings for HMOs, nursing homes, and insurance companies, announces that Jim Bigl is stepping down from the Board of Directors. Mr. Bigl's decision was based on potential conflicts of interest.

Management Comment:

"It has been a pleasure working closely with Jim. He has been a great friend to the company and will remain so, but due to potential conflicts of interest needs to step down from the Board," said Dr. Chess, Chief Executive Officer. "The Board is currently working to identify candidates to replace Mr. Bigl."

Comment from Jim Bigl:

"HCI is revolutionizing healthcare services for patients and payors alike and I strongly wish the company success in achieving its vision," said Mr. Bigl.

HC Innovations is the holding company for Enhanced Care Initiatives (ECI), which provides specialty care management services for medically unstable, complex patients. These services are performed through a program of 24/7 clinical support and intensive interventions based on care plans guided by a proprietary electronic health record (EHR) system. HCI's corporate strategy is to care for the most costly and needy patients in order to reduce clinical morbidity, prevent unnecessary hospitalizations, increase quality of life and create cost savings. The Company targets its offering to HMOs, other risk-bearing managed care organizations, state Medicaid departments, Medicare and as an on-site subcontractor for disease management companies.

The Company's services are offered through three programs: Easy Care(TM), NP Care(TM), and Quality of Life Care(TM). All of its hands-on operations have the ability to drive down medica
'/>"/>

SOURCE HC Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Access Innovations Provides Support Services for Agis Network
2. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
3. Prize for Cutting-Edge Laser Innovations
4. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
5. Cleveland Clinic Unveils Top 10 Medical Innovations For 2008
6. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
7. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
8. Young Innovations, Inc. Provides Third Quarter Conference Call Details
9. Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc.
10. Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend
11. SPOC, Inc. announces completion of $300,000 follow-on investment by Connecticut Innovations
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Within3 Expands into Mobile Applications 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 1Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 2Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 3Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 4Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 5Orexigen 28R 29 Therapeutics Releases New Efficacy Data for Contrave 28R 29 in Late Breaker Presentations at the 27th Annual Scientific Meeting of The 5754 6URI research couples method targets cancerous tumors 60165 1URI research couples method targets cancerous tumors 60165 2URI research couples method targets cancerous tumors 60165 3URI research couples method targets cancerous tumors 60165 4Scientists are first to observe the global motions of an enzyme copying DNA 10548 1Scientists are first to observe the global motions of an enzyme copying DNA 10548 2Scientists are first to observe the global motions of an enzyme copying DNA 10548 3Scientists are first to observe the global motions of an enzyme copying DNA 10548 4